Literature DB >> 26360930

Multicomponent Reaction of Z-Chlorooximes, Isocyanides, and Hydroxylamines as Hypernucleophilic Traps. A One-Pot Route to Aminodioximes and Their Transformation into 5-Amino-1,2,4-oxadiazoles by Mitsunobu-Beckmann Rearrangement.

Valentina Mercalli1, Alberto Massarotti1, Monica Varese1, Mariateresa Giustiniano2, Fiorella Meneghetti3, Ettore Novellino2, Gian Cesare Tron1.   

Abstract

Synthetically useful aminodioximes are prepared via a novel three-component reaction among Z-chlorooximes, isocyanides, and hydroxylamines by exploiting the preferential attack of isocyanides to nitrile N-oxides via a [3 + 1] cycloaddition reaction. The results of quantum mechanical studies of the reaction mechanism are also discussed. Furthermore, the one-pot conversion of aminodioximes to 1,2,3-oxadiazole-5-amines via Mitsunobu-Beckmann rearrangement is reported for the first time.

Entities:  

Year:  2015        PMID: 26360930     DOI: 10.1021/acs.joc.5b01676

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Facile Synthesis of Tricyclic 1,2,4-Oxadiazolines-Fused Tetrahydro-Isoquinolines from Oxime Chlorides with 3,4-Dihydroisoquinoline Imines.

Authors:  Kaikai Wang; Yanli Li; Wei Zhang; Rongxiang Chen; Xueji Ma; Mingyue Wang; Nan Zhou
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

2.  Sulfamic acid promoted one-pot multicomponent reaction: a facile synthesis of 4-oxo-tetrahydroindoles under ball milling conditions.

Authors:  Trimurti L Lambat; Ahmed A Abdala; Sami Mahmood; Pankaj V Ledade; Ratiram G Chaudhary; Subhash Banerjee
Journal:  RSC Adv       Date:  2019-12-03       Impact factor: 4.036

3.  Tautomeric-Dependent Lactam Cycloaddition with Nitrile Oxide: Facile Synthesis of 1,2,4-Oxadiazole[4,5-a]indolone Derivatives.

Authors:  Kun-Ming Jiang; Urarika Luesakul; Shu-Yue Zhao; Kun An; Nongnuj Muangsin; Nouri Neamati; Yi Jin; Jun Lin
Journal:  ACS Omega       Date:  2017-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.